Akebia Therapeutics
AKBA
#9082
Rank
A$0.26 B
Marketcap
A$0.96
Share price
-3.67%
Change (1 day)
-78.61%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: A$0.26 Billion

As of October 2026 Akebia Therapeutics has a market cap of A$0.26 Billion. This makes Akebia Therapeutics the world's 9082th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.26 B-59.38%
2025A$0.65 B-3.85%
2024A$0.68 B99.49%
2023A$0.34 B119.82%
2022A$0.15 B-71.4%
2021A$0.54 B3.63%
2020A$0.52 B-52.08%
2019A$1.09 B19.7%
2018A$0.91 B1.91%
2017A$0.90 B62.67%
2016A$0.55 B1.78%
2015A$0.54 B87.69%
2014A$0.28 B

End of Day market cap according to different sources

On Oct 17th, 2026 the market cap of Akebia Therapeutics was reported to be:

A$0.26 Billion
by Nasdaq info icon info icon
A$0.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$886.24 B 331,619.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$411.96 B 154,097.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$336.46 B 125,837.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A$1.75 B 557.99%๐Ÿ‡บ๐Ÿ‡ธ USA